- The Daily Trade
- Posts
- Market Moves: Rocket Lab Soars, Urban Outfitters Shines, and What Trump’s Tariffs Mean for You
Market Moves: Rocket Lab Soars, Urban Outfitters Shines, and What Trump’s Tariffs Mean for You
Ryan Serkes
November 27, 2024
In partnership with
Natural Is planning to list on the Nasdaq
This is a paid advertisement for Med-X’s Regulation CF Offering. Please read the offering circular at https://invest.medx-rx.com
Natural solutions are already better for the environment. Med-X is taking it a step further: their natural pesticides outperform various chemical alternatives. Better yet, they’re taking on private investors as they plan their Nasdaq listing (ticker: MXRX). And you now have a limited time to invest before it happens. Med-X has had 200% revenue growth in five years. And with the pesticide market expected to grow 3X by the end of the decade, now is the perfect time to join them.
Recent Headlines
Technical Analysis Results
RSI Sell | MFI Sell | WillR Sell | AO Sell |
CCI Sell | BBANDS Hold | ULTOSC Sell | STOCH Sell |
Here is how China Resources Power Holdings Co. (CRPJY) and NiSource (NI) have performed compared to their sector so far this year.
Southern's unit Southern Power expands its Millers Branch Solar Facility, adding 132 MW to reach a total capacity of 512 MW.
RSI Sell | MFI Hold | WillR Sell | AO Sell |
CCI Sell | BBANDS Sell | ULTOSC Sell | STOCH Sell |
Needham has initiated coverage of the aviation sector, delivering a bullish outlook on Joby (JOBY) and Archer Aviation (ACHR) with Buy ratings. The firm sees Joby as best positioned to capture early market share in air taxi development. Meanwhile, Archer Aviation receives praise for its robust $6 billion aircraft order book. Market Domination Anchors Julie Hyman and Josh Lipton dive into the details of these ratings. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Angel Smith
SANTA CLARA, Calif., November 12, 2024--Archer Aviation Inc. (NYSE: ACHR), a leader in electric vertical takeoff and landing (eVTOL) aircraft, today announced Dr. Talib Alhinai as its UAE Lead. Dr. Alhinai, who currently serves on the Board of Directors for the GCAA, the UAE’s aviation regulator, will be responsible for spearheading the planned launch of Archer’s electric air taxis in the region.
RSI Sell | MFI Sell | WillR Sell | AO Sell |
CCI Sell | BBANDS Hold | ULTOSC Sell | STOCH Sell |
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the electrical systems industry, including Vertiv (NYSE:VRT) and its peers.
OSIS secures an $11-million order for its Optoelectronics division to advance medical innovation.
RSI Sell | MFI Sell | WillR Sell | AO Sell |
CCI Sell | BBANDS Hold | ULTOSC Sell | STOCH Sell |
Bitcoin has continued its massive gains,rising around the $100,000 mark in the weeks since the election based on expectations of improved regulatory treatment. But for the cryptocurrency, this rise just might be its own catalyst.
Bitcoin surpassed $98,000 amid investor optimism over the incoming Trump administration's crypto policies.
RSI Sell | MFI Sell | WillR Sell | AO Sell |
CCI Sell | BBANDS Sell | ULTOSC Sell | STOCH Hold |
Poseida Therapeuticsstock skyrocketed Tuesday afterRocheclosed a deal to acquire the California-based biopharmaceutical company.Rochea Swiss healthcare company, agreed to pay $9 a share in cash at closing.The transaction, which is expected to wrap up in the first quarter of 2025, will help Roche “drive further progress in allogenic cell therapy,” according to Chief Medical Levi Garraway.
RHHBY is all set to acquire Poseida Therapeutics, Inc. and ramp up its pipeline with off-the-shelf cell therapies.
RSI Buy | MFI Hold | WillR Buy | AO Buy |
CCI Buy | BBANDS Buy | ULTOSC Buy | STOCH Hold |
By separating from Concentra, which specializes in occupational health services, SEM can better allocate resources to its primary segments.
Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced that we have completed our previously announced distribution (the "Distribution") of 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE: CON) owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock. After the completion of the Di
We want to hear from YOU!
Your feedback is important to us. We’re always looking for ways to improve and would love to hear your thoughts on how we can make this newsletter even better for you. Whether you have suggestions, ideas, or just want to share what you enjoy most, we’re all ears.
Simply reply to this email with your thoughts. Every comment helps us serve you better.
Thank you for being a valued reader.
How would you rate today's newsletter?If there's anything I can do better, please let me know so I can make improvements! |
Technical Indicator Information
Relative Strength Index (RSI) | Period: 14 days | Overvalued threshold: 70 | Undervalued threshold: 30
Money Flow Index (MFI) | Period: 14 days | Overvalued threshold: 80 | Undervalued threshold: 20
Williams Percent Range (WillR) | Period: 14 days | Overvalued threshold: -20 | Undervalued threshold: -80
Aroon Oscillator (AO) | Period: 14 days | Overvalued threshold: 75 | Undervalued threshold: -75
Moving Average Convergence/Divergence (MACD) | Period: 26/12/9 days | Overvalued threshold: MACD crosses below MACD Signal | Undervalued threshold: MACD crosses above MACD Signal
Stochastic Oscillator (STOCH) | Period: 14/3/3 days | Overvalued threshold: %K crosses below %D above 80 | Undervalued threshold: %K crosses above %D below 20
Commodity Channel Index (CCI) | Period: 20 days | Overvalued threshold: 100 | Undervalued threshold: -100
Bollinger Bands (BBANDS) | Period: 20 days | Overvalued threshold: price >= upper band | Undervalued threshold: price <= lower band
Parabolic Stop and Reverse (SAR) | Period: variable 50 - 100 days | Overvalued threshold: SAR crosses above price | Undervalued threshold: SAR crosses below price
Triple Exponential Average (TRIX) | Period: 15 days | Overvalued threshold: TRIX crosses below 0 | Undervalued threshold: TRIX crosses above 0
Ultimate Oscillator (ULTOSC) | Period: 28/14/7 days | Overvalued threshold: 70 | Undervalued threshold: 30
Directional Movement Index (DMI) | Period: 14 days | Overvalued threshold: PlusDI crosses below MinusDI | Undervalued threshold: PlusDI crosses above MinusDI
Average Directional Index (ADX) | Period: variable 14 days | Requirement: >= 25
Analysis is only performed on securities with market caps in excess of $100 million and with daily trade volume in excess of $50 million.
Disclaimers
The information in our newsletter is not intended to constitute investment advice and is not designed to meet your personal financial situation. It is provided for information purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor or a group of investors. It should not be assumed that any investments in securities, companies, sectors or markets identified and described will be profitable. We strongly advise you to discuss your investment options with your financial advisor prior to making any investments, including whether any investment is suitable for your specific needs.
Although we obtain information contained in our newsletter from sources we believe to be reliable, we cannot guarantee its accuracy. The analysis provided in this newsletter is based on the prior trading day’s closing prices and may not reflect after-hours trading, earnings announcements, or other significant market events that occur outside regular trading hours. As such, any data or commentary may not fully capture the latest market movements or emerging factors. For the most current and comprehensive view, please consider additional sources or consult with a qualified financial professional.
The information provided in our newsletter is private, privileged, and confidential information, licensed for your sole individual use as a subscriber. We reserve all rights to the content of this newsletter. Forwarding, copying, disseminating, or distributing this newsletter in whole or in part, including substantial quotation of any portion the publication or any release of specific investment recommendations, is strictly prohibited.